← brief for 2026-09-23 · Slowing decline

Non-albumin proteinuria as a candidate biomarker of treatment response to finerenone in diabetic kidney disease: a real-world cohort study.

Article C Peer reviewed Observational

Key takeaways

This study looked at 477 people with diabetic kidney disease taking finerenone. It found that a type of protein in the urine may show how well the drug is working. This is an observational study, so it shows a link, not proof of cause.

Who did this work

Choi MS · Kim HW · Yu M · Lee M · Lee YH · Kang ES · Cha BS · Lee BW

Source

Article · PubMed, the drug frontier · 2026 Sep 8
https://pubmed.ncbi.nlm.nih.gov/42774062/